Skip to main content
Clinical Trials/CTRI/2023/06/054487
CTRI/2023/06/054487
Not yet recruiting
Phase 2

A randomized controlled clinical study to evaluate the efficacy of parijatak ghan vati And nirgundi ghan vati in the management of gridhrasi w.s.r. to sciatica

SMITA DINKAR MULE0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
SMITA DINKAR MULE
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
SMITA DINKAR MULE

Eligibility Criteria

Inclusion Criteria

  • Diagnosed patient of Sciatica using Digital X\-Ray(lumber spine)
  • Diagnosed patient having signs of Gridhrasi
  • Patient willing to participate in the trial.

Exclusion Criteria

  • Patients with other systemic disorders like Diabetes, CA spine Patients with history of any direct or indirect trauma to spine. Patient having congenital deformities of spine. Pregnant females and Lactating mothers. Immunocompromised patients. Patient requiring emergency surgical intervention.

Outcomes

Primary Outcomes

Not specified

Similar Trials